Balboa Wealth Partners’s CVS Health CVS Stock Holding History

Balboa Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Buy	+2,018	New	+$180K	0.03%	438
2026 Q1	–	Sell	-2,673	Closed	-$212K	–	462
2025 Q4	$212K	Buy	+2,673	New	+$211K	0.04%	370
2024 Q3	–	Sell	-3,765	Closed	-$222K	–	345
2024 Q2	$222K	Buy	3,765 +983	+35%	+$61.5K	0.06%	236
2024 Q1	$222K	Sell	2,782 -325	-10%	-$24.8K	0.07%	209
2023 Q4	$245K	Buy	3,107 +105	+3%	+$7.47K	0.08%	190
2023 Q3	$210K	Sell	3,002 -762	-20%	-$54K	0.08%	203
2023 Q2	$260K	Sell	3,764 -11	-0.3%	-$783	0.09%	183
2023 Q1	$281K	Buy	3,775 +691	+22%	+$57.9K	0.11%	171
2022 Q4	$287K	Sell	3,084 -296	-9%	-$28.6K	0.13%	161
2022 Q3	$322K	Buy	+3,380	New	+$335K	0.14%	128

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Balboa Wealth Partners's CVS Position: Q2 2026 in Review

Balboa Wealth Partners opened a new position in CVS Health (CVS) in Q2 2026: 2,018 shares worth $209K. The stake represents 0.03% of the portfolio and ranks #438 among its holdings. This is a return to the name: Balboa Wealth Partners previously reported a position in CVS as recently as Q4 2025.

Balboa Wealth Partners first reported a position in CVS in Q3 2022 and has held it in 10 quarters since. The position peaked at $322K in Q3 2022. 2,071 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Balboa Wealth Partners held 2,018 shares of CVS Health worth $209K as of Q2 2026.
CVS Health was a new Balboa Wealth Partners position in Q2 2026.
CVS Health made up 0.03% of Balboa Wealth Partners's portfolio in Q2 2026, its #438 holding.
Balboa Wealth Partners first reported a position in CVS Health in Q3 2022 and has held it in 10 quarters since.
Balboa Wealth Partners's CVS Health position peaked at $322K in Q3 2022.
2,071 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Balboa Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.